Ironwood Pharmaceuticals (IRWD) Times Interest Earned (2010 - 2026)

Ironwood Pharmaceuticals has disclosed Times Interest Earned across 17 years of filings, most recently posting $7.94 for Q1 2026.

• Times Interest Earned for Q1 2026 came in at $7.94, up 320.11% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.44 (up 119.98% YoY), and the FY2025 annual result was $0.45, down 84.07% from the prior year.
• Times Interest Earned came in at $7.94 for Q1 2026 at Ironwood Pharmaceuticals, up from -$9.76 in the prior quarter.
• In the past five years, Times Interest Earned ranged from a high of $44.93 in Q3 2022 to a low of -$588.66 in Q2 2023.
• The 5-year median for Times Interest Earned is $4.07 (2023), against an average of -$30.02.
• Across the five-year window, Times Interest Earned surged 440.57% in 2022 and plunged 2434.34% in 2023, its largest moves.
• Ironwood Pharmaceuticals' Times Interest Earned stood at -$84.51 in 2022, then soared by 105.28% to $4.46 in 2023, then decreased by 20.84% to $3.53 in 2024, then plunged by 376.36% to -$9.76 in 2025, then soared by 181.32% to $7.94 in 2026.
• The last three Times Interest Earned figures came in at $7.94 (Q1 2026), -$9.76 (Q4 2025), and $8.95 (Q3 2025), per Business Quant data.